+61 (03) 9482 3940 157 Heidelberg Rd, Northcote, VIC 3070 www.renerve.com.au ASX Announcement 12 August 2026 Quarterly Report Webinar 11am (AEST) Wednesday 19 August 2026 ReNerve Limited (ASX, " ReNerve " or "the Company "), an Australian biotechnology company...
Quarterly Investor Webinar
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Renerve
- ReNerve Secures Marketing Approval in India
- ReNerve Secures Marketing Approval in the Philippines
- Change of Director's Interest Notice - J Chick
- Q4 FY26 Activities Report and Appendix 4C
- ReNerve Secures up to A$5 Million Funding Facility
Later from Renerve
- Quarterly Investor Presentation
- Proposed issue of securities - RNV
- Application for quotation of securities - RNV
- Cleansing Notice
- ReNerve - Appendix 4E
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve